Results 11 to 20 of about 199,596 (304)

Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation [PDF]

open access: yesCase Reports in Hematology, 2015
Monitoring of the JAK2 V617F allele burden in myeloproliferative neoplasms after allogeneic stem cell transplantation is useful to determine levels of residual disease and has the potential to detect early relapse and guide subsequent clinical ...
Stephen E. Langabeer   +5 more
doaj   +2 more sources

Molecular Profiling and Minimal Residual Disease Monitoring in Multiple Myeloma Patients: A Literature Review [PDF]

open access: yesКлиническая онкогематология, 2021
A personalized approach is a promising tool for malignant neoplasm (MN) treatment. Gaining success and benefit assessment of this approach were considerably facilitated by the implementation of the new generation sequencing techniques which allow to ...
Aleksandra Vladimirovna Semyanikhina   +1 more
doaj   +3 more sources

Nodular Fasciitis Complicating a Staged Surgical Excision of Dermatofibrosarcoma Protuberans [PDF]

open access: yesCase Reports in Dermatological Medicine, 2016
Dermatofibrosarcoma protuberans (DFSP) is an unusual spindle cell tumor with a high rate of local recurrence with traditional excision. Fortunately, Mohs micrographic surgery yields excellent cure rates for this neoplasm due to contiguous tumor spread ...
C. Helen Malone   +4 more
doaj   +2 more sources

Adrenal Oncocytic Neoplasm with Paradoxical Loss of Important Mitochondrial Steroidogenic Protein: The 18 kDA Translocator Protein [PDF]

open access: yesCase Reports in Endocrinology, 2017
The adrenal glands produce a variety of hormones that play a key role in the regulation of blood pressure, electrolyte homeostasis, metabolism, immune system suppression, and the body’s physiologic response to stress.
Roberto Ruiz-Cordero   +5 more
doaj   +2 more sources

Intracholecystic tubular non-mucinous neoplasm (ICTN) of the gallbladder: a clinicopathologically distinct, invasion-resistant entity [PDF]

open access: yes, 2021
© 2020, Springer-Verlag GmbH Germany, part of Springer Nature.Preinvasive tumor-forming gallbladder neoplasms that are composed of small, non-mucinous tubules with complex architecture remain a poorly characterized group.
Bagci P.   +14 more
core   +6 more sources

Intracytoplasmic antigen study by flow cytometry in hematolymphoid neoplasm [PDF]

open access: yesIndian Journal of Pathology and Microbiology, 2009
Flow cytometric detection of intracellular antigens has become a standard method in establishing proper leukemic cell lineage affiliation. It has a non-debatable contribution to the diagnosis of hematolymphoid neoplasm as well as in minimal residual ...
Gujral Sumeet   +5 more
doaj   +1 more source

Appendiceal Mucinous Neoplasm in Adolescence: Diagnosis, Management, and Surveillance [PDF]

open access: yes, 2023
This case report describes a 17-year-old patient with a low-grade appendiceal mucinous neoplasm. The patient presented with non-bloody diarrhea, abdominal pain, and weight loss.
Wilsey, Michael   +8 more
core   +1 more source

Primary undifferentiated pleomorphic sarcoma (Malignant fibrous histiocytoma) of the lung: A case report

open access: yesClinical Case Reports, 2020
Primary UPS of the lung, so‐called MFH, is a rare aggressive neoplasm and known to be a high risk of recurrence and metastasis. Surgical resection without residual tumor is the main option of treatment and the best chance for long‐term survival.
Yudai Miyashita   +2 more
doaj   +1 more source

The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2023
Background/Aims We evaluated the role of next-generation sequencing (NGS)-based disease monitoring for elderly patients diagnosed with acute myeloid leukemia (AML) who received decitabine therapy.
Mihee Kim   +14 more
doaj   +1 more source

Minimal Residual Disease in Colorectal Cancer: Are We Finding the Needle in a Haystack?

open access: yesCells, 2023
Despite significant advances in the surgical and systemic therapy of colorectal cancer (CRC) in recent decades, recurrence rates remain high. Apart from microsatellite instability status, the decision to offer adjuvant chemotherapy to patients with CRC ...
Alexandre A. Jácome, Benny Johnson
doaj   +1 more source

Home - About - Disclaimer - Privacy